01-06-2021
National guidelines for the management of acute otitis media (AOM) play a vital role in antibiotic stewardship (ABS). This review evaluates European guidelines for AOM in children based on methodological quality, Strength of Recommendations and consideration of ABS. While major similarities were found, the authors encourage development of centrally produced, locally adapted AOM guidelines to reduce unnecessary administration of antibiotics.
01-06-2021
In North America, acute rhinosinusitis (ARS) is a major driver of antibiotic consumption. Prescribers are encouraged to revisit diagnostic criteria for acute bacterial rhinosinusitis (ABRS) when evaluating patients with ARS, to help identify those who require antibiotics, and prescribe the most appropriate antibiotic treatment.
01-06-2021
Quality indicators (QIs) are an initial step toward improving the quality of care provided to patients. Acute bacterial rhinosinusitis (ABRS), a complication of upper respiratory tract infections (URTIs), lacks specifi c QIs. This study proposes 7 ABRS specific QIs to evaluate the diagnosis and management that reduces symptoms, improves quality of life, and prevents complications.
01-06-2021
Acute otitis media (AOM), acute bacterial rhinosinusitis (ABRS) and the lower respiratory tract infection, community-acquired pneumonia (CAP), are often treated with antibiotics. This paper evaluates the pharmacological properties of the preferred agents, amoxicillin and amoxicillin + clavulanic acid, compared with oral cephalosporins also prescribed in AOM, ABRS, and CAP. The analysis revealed that oral cephalosporins provide unnecessarily broad spectra of activity.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Inactivated quadrivalent influenza vaccine <br> Vaccines
Levetiracetam<br> Neurology
Salbutamol<br> Respiratory
Fluticasone-propionate<br> Dermatology
Lamotrigine<br> Neurology
Umeclidinium/Vilanterol<br> Respiratory
Fluticasone furoate/Vilanterol inhalation powder<br> Respiratory
Cetirizine dihydrochloride<br>Allergy
Dutasteride/Tamsulosin hydrochloride<br> Urology
Salmeterol/Fluticasone propionate<br> Respiratory
Only Anoro has positive head-to-head data vs. Spiolto
GlaxoSmithKline (GSK) UK healthcare professional website search results.
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.
Fluticasone furoate<br> Allergy
Fluticasone furoate<br> Allergy
Levetiracetam<br> Neurology
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
BPH | GSK Pharma | Healthcare Professionals
Inactivated hepatitis A and rDNA hepatitis B vaccine(adsorbed)</br> Vaccines
Meningococcal Group A,C,W135 & Y Conjugate Vaccine <br> Vaccines
Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine
Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine
Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine
Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine
Varicella-zoster vaccine (live, attenuated)<br> Vaccines
An overview of clinical data for Anoro Ellipta (umeclidinium/vilanterol).
An overview of clinical data for Anoro Ellipta (umeclidinium/vilanterol).
Guideline-defined control page for Seretide Adult
Guideline-defined control page for Seretide Adult
Keppra (levetiracetam) | A page detailing the reasons why an anti-epileptic drug (AED) choice in women with epilepsy is important.
Information for healthcare professionals about asthma, how it impacts patients and treatment goals
A comprehensive source of respiratory information and services, designed to help you support your patients.
Impact around the world. Real-world impact on overall IPD: no notable difference between higher-valent PCVs
Sweden: Comparable impact of PCVs. Real-world impact on overall IPD: no significant difference between higher-valent PCVs
Welcome to our Synflorix Video Center for HCPs
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries. Healthy aging overview.
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries
(dutasteride/tamsulosin HCL) Capsules <br> Urology
Inactivated quadrivalent influenza vaccine<br> Vaccines
Particle size page for Seretide Adult
Hepatitis A(Inactivated) and Hepatitis B (rDNA) (HAB) vaccine(adsorbed)<br> Vaccines
GSK Vaccines Expert Videos
Meningococcal Group A,C,W135 & Y Conjugate Vaccine<br> Vaccines
tetanus, diphtheria, acellular pertussis vaccine <br> Vaccines
Keppra (levetiracetam) | The Keppra Story | Guideline recommendations |
GSK Vaccines Expert Videos
We provide healthcare professionals in Malaysia with relevant information on GSK products and related therapy areas, events and educational content designed for HCPs.
Educational resources and guides designed to help healthcare professionals support their patients.
Pneumococcal polysaccharide and non-typeable haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed<br> Vaccines
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.
Information about our classic respiratory portfolio and other resources designed to help healthcare professionals support their patients.
Pneumococcal polysaccharide and non-typeable haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed<br> Vaccines
The safety of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) was extensively studied in 2 large phase 3 clinical trials
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.
Pneumococcal polysaccharide and non-typeable haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed<br> Vaccines
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
amoxicillin-clavulanate<br>Anti infectives
Cetirizine dihydrochloride </br> Allergy
Herpes zoster </br> Vaccines
Mepolizumab </br> Respiratory
Belimumab<br>Specialty Care
Tetanus, diphtheria, acellular pertussis vaccine <br> Vaccines
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.
Amoxicillin/Clavulanic acid<br/> Anti-Infectives
Respiratory syncytial virus vaccine (adults)<br>Vaccines
umeclidinium bromide/vilanterol
Umeclidinium/Vilanterol<br> Respiratory
umeclidinium bromide/vilanterol
Salmeterol xinafoate / Fluticasone propionate<br> Respiratory
Keppra, epilepsy, CNS, seizures, type of epilepsy, efficacy, efficacy keppra, Efficacy ASMs, ILAE report
Seretide MDI page for Seretide Adult
Seretide Diskus page for Seretide Adult
Recognition page for Seretide Adult
Keppra (levetiracetam) | Resources | Watch informational videos and webcasts by experts
Keppra, epilepsy, CNS, seizures, type of epilepsy, diagnosis of epilepsy, anti seizure medication, anti epileptic drug, SUDEP, brain and heart, managing epilepsy, focal epilepsy
Visible and invisible symptoms page for Seretide Adult
Guideline-defined control page for Seretide Adult
Safety page for Seretide Adult
Levetiracetam<br> Neurology
fluticasone propionate/salmeterol
symptoms and exacerbations page for Seretide Adult
Sustained asthma control page for Seretide Adult
New Versus Old: Study Overview
This page contains an overview of the Rotarix platform
umeclidinium bromide/vilanterol
Shingles Action Week Infographic 2026 MY
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) product information and resources to support HCPs in their daily practice.
This page contains an overview of the Rotarix platform
fluticasone furoate<br>Respiratory
Information on the Safety & Dosing of Avamys, high receptor affinity, tissue retention, pharmacodynamic profile and bioavailability
A summary of how positively Avamys (fluticasone furoate) is regarded in international guidelines
A page detailing Avamys efficacy vs MFNS. Avamys has preferable sensory attributes compared to MFNS.
A page on Avamys Device’s Efficacy. Avamys is delivered with a once-daily gentle fine mist via a patient-friendly, easy-to-use device.
A page detailing Avamys Comparison. Avamys has preferable sensory attributes compared to MFNS.
Fluticasone furoate<br> Allergy
Rotavirus Vaccine (Live Attenuated, Oral) IP<br> Vaccines
Levocetirizine dihydrochloride<br> Allergy
Dutasteride/Tamsulosin hydrochloride <br> Urology
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) nearly eliminates the risk of developing PHN by preventing shingles
SHINGRIX delivered >90% efficacy against shingles in all age segments ≥50 years old
Recommend the shingles vaccine specifically formulated to address age-related decline in immunity
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is recommended by the CDC for the prevention of shingles (herpes zoster) and related complications for immunocompetent adults aged ≥50 years.
Patients ≥50 years old are at risk for shingles, no matter how healthy they may feel
niraparib<br>ZEJULA's adjustable dosing maintains efficacy and enables long-term treatment
niraparib<br>Benefits of ZEJULA in gBRCAm patients
niraparib<br>Durable efficacy with ZEJULA in patients with recurrent ovarian cancer
niraparib<br>ZEJULA has a well-established long-term safety and tolerability profile
niraparib<br>Benefits of ZEJULA in 𝘉𝘙𝘊𝘈m patients
niraparib<br>Benefits of ZEJULA in HRd BRCAwt patients
niraparib<br>ZEJULA is an established choice in second-line maintenance
niraparib<br>Once-daily individualised dose with ZEJULA in first-line maintenance
niraparib<br>Proven efficacy with ZEJULA in patients with advanced ovarian cancer
niraparib<br>ZEJULA offers an established safety and tolerability profile
niraparib<br>ZEJULA is now approved in first-line maintenance
Meningococcal group B Vaccine (rDNA, component, adsorbed) <br>Vaccines
fluticasone furoate/vilanterol<br> Respiratory